Overview

Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The study will assess the total testosterone and sex hormone-binding globulin levels in men with type 2 diabetes before and after continuous subcutaneous insulin infusion and hypoglycemic drugs treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Majianhua
Treatments:
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
Dapagliflozin
Hypoglycemic Agents
Insulin
Insulin, Globin Zinc
Metformin
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate